Literature DB >> 31449807

Treatment strategies against diabetes: Success so far and challenges ahead.

Rubiya Khursheed1, Sachin Kumar Singh2, Sheetu Wadhwa1, Bhupinder Kapoor1, Monica Gulati1, Rajan Kumar1, Arya Kadukkattil Ramanunny1, Ankit Awasthi1, Kamal Dua3.   

Abstract

The growing disease burden of diabetes mellitus is an important public health concern, affecting over 400 million people globally. This epidemic, if not controlled in time, leads to life threatening complications, compromise in quality of life, and eventually mortality. Over time, many attempts have been made for the effective treatment of diabetes but true success has never been achieved. Pharmacological and non-pharmacological approaches for the treatment of hyperglycaemia have been ever-evolving due to limitations of current therapies. Non pharmacological management which includes diet management and exercise, has been the primary focus for self-management of diabetes. The pharmacological management includes oral antihyperglycaemics, phytoconstituents, and combination products. Advancements such as nanocarrier delivery systems have been made in drug delivery to overcome the challenges such as poor bioavailability associated with conventional dosage forms currently employed in diabetes treatment. In recent years, much emphasis has been given to synbiotics that act on gut microbiota, as an emerging therapy for diabetes. The current review discusses different treatment strategies for diabetes management starting from insulin therapy to synbiotics. The combination of herbal phytoconstituents with synthetic drugs, synthetic drug combinations, novel drug delivery systems for insulin are highlighted. Moreover, the role of gut dysbiosis in diabetes and its treatment by administration of synbiotics in various clinical as well as non clinical studies has been discussed in detail.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes; Formulations; Herbal drugs; Insulin; Mushrooms; Synbiotics

Mesh:

Substances:

Year:  2019        PMID: 31449807     DOI: 10.1016/j.ejphar.2019.172625

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  Protein tyrosine phosphatases (PTPs) in diabetes: causes and therapeutic opportunities.

Authors:  Chiranjeev Sharma; Youllee Kim; Dohee Ahn; Sang J Chung
Journal:  Arch Pharm Res       Date:  2021-02-15       Impact factor: 4.946

2.  Synthesis and Evaluation of Coumarin-Chalcone Derivatives as α-Glucosidase Inhibitors.

Authors:  Chun-Mei Hu; Yong-Xin Luo; Wen-Jing Wang; Jian-Ping Li; Meng-Yue Li; Yu-Fei Zhang; Di Xiao; Li Lu; Zhuang Xiong; Na Feng; Chen Li
Journal:  Front Chem       Date:  2022-06-27       Impact factor: 5.545

3.  Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors.

Authors:  Anita Nasli Esfahani; Aida Iraji; Amir Alamir; Shahram Moradi; Mohammad Sadegh Asgari; Samanesadat Hosseini; Somayeh Mojtabavi; Ensieh Nasli-Esfahani; Mohammad Ali Faramarzi; Fatemeh Bandarian; Bagher Larijani; Haleh Hamedifar; Mir Hamed Hajimiri; Mohammad Mahdavi
Journal:  Mol Divers       Date:  2021-09-13       Impact factor: 3.364

4.  Antihyperglycemic and Antilipidemic Properties of a Tea Infusion of the Leaves from Annona cherimola Miller on Streptozocin-Induced Type 2 Diabetic Mice.

Authors:  Jesús Martínez-Solís; Fernando Calzada; Elizabeth Barbosa; Miguel Valdés
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

5.  Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors.

Authors:  Muhammad Tariq Shehzad; Aqeel Imran; Abdul Hameed; Mariya Al Rashida; Marium Bibi; Maliha Uroos; Asnuzilawati Asari; Shafia Iftikhar; Habsah Mohamad; Muhammad Nawaz Tahir; Zahid Shafiq; Jamshed Iqbal
Journal:  RSC Adv       Date:  2021-05-11       Impact factor: 3.361

6.  Antidiabetes constituents, cycloartenol and 24-methylenecycloartanol, from Ficus krishnae.

Authors:  Ajikumaran Nair Sadasivan Nair; Reshma Vijayakumari Raveendran Nair; Aroma Prasanna Rajendran Nair; Akhila Sasikumar Nair; Sabu Thyagarajan; Anil John Johnson; Sabulal Baby
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

7.  Silencing cyclophilin A improves insulin secretion, reduces cell apoptosis, and alleviates inflammation as well as oxidant stress in high glucose-induced pancreatic β-cells via MAPK/NF-kb signaling pathway.

Authors:  Tangying Li; Huibiao Quan; Huachuan Zhang; Leweihua Lin; Qianying Ou; Kaining Chen
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 8.  Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.

Authors:  Qichao Hu; Caiyan Qu; Xiaolin Xiao; Wenwen Zhang; Yinxiao Jiang; Zhao Wu; Dan Song; Xi Peng; Xiao Ma; YanLing Zhao
Journal:  Chin Med       Date:  2021-08-07       Impact factor: 5.455

Review 9.  Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy.

Authors:  Saikat Dewanjee; Pratik Chakraborty; Biswajit Mukherjee; Vincenzo De Feo
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

Review 10.  Molecules Isolated from Mexican Hypoglycemic Plants: A Review.

Authors:  Sonia Marlen Escandón-Rivera; Rachel Mata; Adolfo Andrade-Cetto
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.